Tumor-induced osteomalacia

Clinical Rheumatology

Volumn 26, Issue 9, 2007, Pages 1575-1579

  Kaul, Mala ^a   Silverberg, Miriam ^b   DiCarlo, Edward F ^a,c   Schneider, Robert ^a,c   Bass, Anne R ^a,c   Erkan, Doruk ^a,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Bone biology; Hypophosphatemia; Osteomalacia; Tumor

Indexed keywords

ALKALINE PHOSPHATASE; ANALGESIC AGENT; CALCITRIOL; TETRACYCLINE; VITAMIN D;

ADULT; ARM DISEASE; ARTICLE; ASTHMA; BONE BIOPSY; BONE SCINTISCANNING; CASE REPORT; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENERAL CONDITION DETERIORATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; LABORATORY TEST; LOW BACK PAIN; ONCOGENIC OSTEOMALACIA; OSTEOMALACIA; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; SUBCUTANEOUS TISSUE TUMOR; VITAMIN BLOOD LEVEL; WALKING DIFFICULTY;

ADULT; FEMALE; HUMANS; HYPOPHOSPHATEMIA; MESENCHYMOMA; OSTEOMALACIA; SOFT TISSUE NEOPLASMS;

EID: 34547592457     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0468-y     Document Type: Article

References (17)

1. Prader V, Illig R, Vehlinger E, Stalder G (1959) Rachitis, infolge, knochen tumors. Helv Paediatr Acta 14:554-565
2. Jonsson K, Zahradnik B, Larsson T et al (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656-1663
3. Carpenter T (2003) Oncogenic osteomalacia - a complex dance of factors. N Engl J Med 348:1705-1708
4. Seufert J, Ebert K, Muller J et al (2001) Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 345:1883-1888
5. Edmister KA, Sundaram M (2002) Oncogenic osteomalacia. Semin Musculoskelet Radiol 6:191-196
6. Nomura G, Kodshino Y, Morimoto H (1981) Vitamin D resistant hypophosphatemic osteomalacia associated with osteosarcoma of the mandible: Report of a case. Jpn J Med 21:35-39
7. Hasegawa T, Shimoda T, Yokoyama R (1999) Intracortical osteoblastic osteosarcoma with oncogenic rickets. Skelet Radiol 28:41-45
8. Folpe A, Fanburg-Smith J, Billings S et al (2004) Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity. Am J Surg Pathol 28:1-30
9. Garcia C, Spencer R (2002) Bone and In-111 octreotide imaging in oncogenic osteomalacia: A case report. Clin Nucl Med 27:582-583
10. Sahin M, Basoglu T, Albayrak S (2001) Pentavalent technetium-99m DMSA uptake in pseudofractures of osteomalacia. Clin Nucl Med 26:62
11. Jan de Beur SM (2005) Tumor induced osteomalacia. JAMA 94:1260-1267
12. Shimada T, Mizutani S, Muto T et al (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500-6505
13. Yamashita T, Konsishi M, Miayke A et al (2002) Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of themitogen-activated protein kinase pathway. J Biol Chem 277:28265-28270
14. Shimada T, Muto T, Urakawa I et al (2002) Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 143:3179-3182
15. Nelson A, Bligh R, Mirams M et al (2003) Fibroblast growth factor 23: A new clinical marker for oncogenic osteomalacia. J Clin Endocrinol Metab 88:4088-4094
16. Takeuchi Y, Suzuki H, Ogura S et al (2004) Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab 89:3979-3982
17. Schapira D, Izhak O, Nachtigal A et al (1995) Tumor induced osteomalacia. Semin Arthritis Rheum 25:35-46